Nephros Launches the Nephros Water Institute to Lead National Water Safety Education
Rhea-AI Summary
Nephros (Nasdaq: NEPH) launched the Nephros Water Institute to formalize and expand its national water-safety education efforts. In 2025 the company reached nearly 1,000 professionals through webinars, national talks, and trainings addressing ASHRAE 514, AAMI ST108, and emergency preparedness.
The Institute will deliver a structured, evidence-based curriculum and a monthly 2026 calendar covering Joint Commission guidance, worker safety at sinks/eyewash stations, construction water-safety links, compounding water quality, federal potable-water expectations, and dialysis water purity.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, NEPH declined 2.93%, reflecting a moderate negative market reaction. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $52M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus 1 Up 1 Down
Peers showed mixed moves: MLSS up 6.82%, HBIO up 6.19%, POCI down 4.82%, NXGL down 2.59%, RVP down 0.3%. Momentum scanner flagged MLSS moving down 5.37% and NXGL up 10.36% on no news, suggesting stock-specific action rather than a unified sector trend around this announcement.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 06 | Q3 2025 earnings | Positive | -8.6% | Reported Q3 revenue and net income growth with continued profitability. |
| Oct 30 | Earnings call schedule | Neutral | +2.9% | Announced date and access details for Q3 2025 results call. |
| Oct 08 | Product launch | Positive | -9.2% | Launched 19-Series PFAS filter for point-of-use potable water protection. |
| Aug 07 | Q2 2025 earnings | Positive | +35.0% | Delivered strong Q2 revenue growth and third consecutive profitable quarter. |
| Jul 31 | Earnings call schedule | Neutral | -3.7% | Set timing and details for upcoming Q2 2025 earnings call. |
Recent history shows strong operational and product news sometimes met with negative reactions (e.g., Q3 earnings and PFAS filter launch), while other strong results saw sizable gains, indicating inconsistent post-news trading patterns.
Over the last few months, Nephros reported strong financial momentum, with Q2 and Q3 2025 results highlighting revenue growth, profitability, and record programmatic sales. The company also launched a new 19-Series PFAS Filter aimed at reducing Total PFAS in potable water, expanding its product lineup. Conference call scheduling releases preceded these earnings updates. Today’s announcement of the Nephros Water Institute extends that trajectory by formalizing education and outreach supporting long-term adoption of its water quality solutions.
Market Pulse Summary
This announcement formalized Nephros’s growing education efforts through the Nephros Water Institute, building on programming that already reached nearly 1,000 professionals across sectors. It highlights focus areas like ASHRAE 514, AAMI ST108, construction-related water risk, and dialysis water purity. In context of prior strong financial results and new PFAS filtration products, investors may watch how expanded webinars, speaking engagements, and curriculum translate into sustained programmatic filter adoption and broader demand for water safety solutions.
Key Terms
joint commission accreditation standards regulatory
icra regulatory
AI-generated analysis. Not financial advice.
New initiative accelerates cross-industry engagement, expands educational reach to drive long-term growth in water quality solutions
SOUTH ORANGE, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leader in point-of-use water filtration, today announced the launch of the Nephros Water Institute, a dedicated education initiative established to formalize the company’s leadership in industry education.
In 2025, Nephros accelerated its national education efforts under the direction of Brianne McGuire, Director of Business Development. Through high-engagement public webinars, national speaking engagements, and tailored trainings with healthcare systems and consulting partners, Nephros directly reached nearly 1,000 professionals. The regulatory and risk-based educational programming addressed critical blind spots in water safety including ASHRAE 514 compliance, AAMI ST108 sterility standards, and emergency preparedness for compromised water events. These efforts contributed to a marked uptick in inbound requests, OEM inquiries, and programmatic filter adoption.
“Across every sector, we continue to see a fundamental gap in understanding of the risks inherent to potable water,” said Brianne McGuire. “The Nephros Water Institute is our answer to that challenge. By providing the practical education leaders need to ensure safety and readiness, while simultaneously deepening our customer relationships and building the foundation for our long-term growth."
With the formalization of the educational efforts under the Institute, Nephros is establishing a structured, evidence-based curriculum to empower stakeholders responsible for water safety, infection prevention, and regulatory readiness.
“Organizations need clarity, not complexity,” said Robert Banks, President and CEO of Nephros. “The Nephros Water Institute ensures that leaders across healthcare and related sectors have access to accurate, practical information to make safer decisions about their water systems. Our mission extends beyond selling filters; we view education as an essential component of our commitment to water safety and our responsibility to the industry.”
2026 and Beyond
Looking ahead to 2026, Nephros will expand its educational footprint with a full calendar of monthly webinars and product spotlights. Planned content includes:
- Guidance on the reorganized Joint Commission accreditation standards
- Considerations for worker safety at sinks and eyewash stations
- Connecting ICRA and WICRA for water safety during construction
- Water quality for pharmaceutical compounding
- Federal expectations for potable water
- Dialysis water purity
A full list of upcoming events is available on our Events & Speaking Engagements page
About Nephros
Nephros is a leading provider of filtration products to medical and commercial markets, offering a wide range of solutions that deliver superior filtration performance. With advanced hollow-fiber technology and effective commercial filter media, Nephros products help protect against waterborne contaminants, ensuring the highest level of water quality.
For more information about Nephros, visit nephros.com
Forward-Looking Statements
This release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding Nephros’ expected benefits of the Nephros Water Institute and other statements that are not historical facts, including statements that may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business and competitive conditions and regulatory reforms. These and other risks and uncertainties are detailed in Nephros’ reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2024, which it may update in Part II, Item 1A – Risk Factors in its Quarterly Reports on Form 10-Q that it has filed or will file hereafter. Nephros does not undertake any responsibility to update the forward-looking statements in this release.
Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com
Robert Banks, CEO
Nephros, Inc.
(201) 343-5202
robert.banks@nephros.com
Judy Krandel, CFO
Nephros, Inc.
(201) 343-5202
judy.krandel@nephros.com